Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-053923
Filing Date
2014-02-14
Accepted
2014-02-14 13:19:00
Documents
1
Group Members
ALEXANDRA GOLLHUBERT BIRNERSTEFAN FISCHERTVM CAPITAL GMBHTVM IV GMBH & CO KGTVM IV MANAGEMENT GMBH & CO. KGTVM MEDICAL VENTURES GMBH & CO KGTVM V LIFE SCIENCE VENTURES MANAGEMENT GMBH & CO. KG

Document Format Files

Seq Description Document Type Size
1 SC 13G d676011dsc13g.htm SC 13G 169811
  Complete submission text file 0001193125-14-053923.txt   171600
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Subject) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87373 | Film No.: 14613937
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TVM CAPITAL CORP 101 ARCH STREET SUITE 1950 BOSTON MA 02110
Business Address C/O TVM CAPITAL CORP 101 ARCH STREET SUITE 1950 BOSTON MA 02110 617-345-9320
TVM V LIFE SCIENCE VENTURES GMBH & CO KG (Filed by) CIK: 0001183073 (see all company filings)

EIN.: 000000000
Type: SC 13G